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Introduction 
Apical pleural thickening with fibrobullous disease 
is common in pleuropulmonary manifestation of 
ankylosing spondylitis (AS). Other forms of pleural 
disease are rare (1) and there are few reports of 
treatment of pleural effusions associated with AS 
(24). We report a case of persistent exudative pleural 
effusion in AS and the therapeutic effects of intra- 
pleural administration of prednisolone. 
Case Report 
A 56-year-old farmer with a 2-yr history of docu- 
mented AS was admitted in May 1993 because of a 
6-month history of persistent pleural effusion and 
increase of dyspnoea. He had a history of mediastinal 
lymphoma 9 yr previously and a skin squamous cell 
carcinoma of the upper lip 4 months previously. Both 
diseases were in complete remission after irradiation 
therapy. His joint disease had required oral 
indomethacin but 1 month before his admission, he 
suffered from multiple gastric ulcers. 
On admission, he was 145 cm tall and weighed 
43 kg. Spinal movements were severely restricted in all 
directions and the thoracic spine was kyphotic. No 
synovitis was apparent in peripheral joints. A chest 
radiograph showed a little left pleural effusion and 
right apical fibrobullous lesions (Plate 1). CT scan 
revealed dilated bronchi and a cavity with thickened 
walls in the right upper lobe, but aspergilloma was not 
detected within the cavity. Radiographs of his spine 
confirmed severe spondylitis and obliteration of the 
sacroiliac joints. Laboratory investigation revealed: 
haemoglobin 98 g dl,-‘, white blood cell count 
4800 mm- 3, with 70% neutrophils, 14% lymphocytes, 
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Plate I Posteroanterior chest radiograph on admission, 
showing a left pleural effusion, right apical fibrobullous 
lesions, and nodular shadows with calcification in the left 
upper lobe. 
13% monocytes, and 3% eosinophils. Erythrocyte sedi- 
mentation rate was 66 mm h ‘, antinuclear antibody 
and rheumatoid factor were negative, and serum pre- 
cipitins against Aspergillus fumigatus was positive. The 
quantification of serum immunoglobulins were as fol- 
lows: IgG, 2371 mg dll’ (range 10481646); IgA, 
300 mg dl ’ (range: 146340); IgM, 139 mg dl- ’ 
(range: 70-170). Arterial blood gases [0, concentra- 
tion of inhaled air (FIO,=0.21] indicated PO, of 68.7 
Torr, PCO, of 45.6 Torr, pH of 7.45, and HCO, of 
31 mmol l- ‘. Sputum culture for tuberculosis and 
aspergillosis remained negative. A tuberculin skin test 
was negative. The HLA type was A3, All, B27, B44, 
CW5, and CW6. Pleural fluid was straw-coloured and 
had total protein of 4.8 g dl- ‘, pH 7.6, glucose 
93 mg dl - ‘, lactate dehydrogenase 147 IU 1 - ‘, and 
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Plate 2 Pleural biopsy specimen reveals fibrous thickening 
with an accumulation of lymphocytes and inflammatory 
cells. 
adenosine deaminase 128U 1 - ‘; tubercle bacilli were 
not seen in the fluid nor grown on culture. Cytology 
was negative for malignant cells. The lymphocytes in 
the effusion were analysed for surface marker using 
monoclonal antibody UCHL - 1 (pan T) or L26 (pan 
B), however there was no monoclonality. 
Despite several pleural punctures over the next 4 
months, the effusion reaccumulated rapidly and the 
characteristics did not change. Percutaneous pleural 
biopsy showed fibrous thickening with an accumula- 
tion of lymphocytes (Plate 2). 
Oral prednisolene therapy was contraindicated 
because of the patient’s gastric ulcers and the possi- 
bility of A. jiimigatus infection of the right upper 
lobe. In October 1993, 20 mg of prednisolone was 
instilled into the left pleural cavity after complete 
drainage of the effusion. Subsequently, the effusion 
reaccumulated a little but did not increase over the 
following 13 months, and his forced vital capacity 
improved from 630 ml to 910 ml. 
Discussion 
Pleural effusion in AS is rare. Rosenow et al. (1) 
reported three out of 2080 patients (0.15%) and 
Spencer et al. (5) found none in 200 patients (0%). In 
contrast, a much higher prevalence was found by 
Nagyhegyi et al. (6) with four out of 86 patients 
(5%). It is not clear whether these differences repre- 
sent true variations in different populations, in 
thresholds of reporting, or in patient selection. A case 
of haemothorax due to spinal fracture in AS has also 
been reported (7). In our case, the fluid was an 
exudate that had a normal glucose content and pH. 
These results are similar to reported cases in AS, 
in contrast with pleural effusions of rheumatoid 
arthritis; glucose and pH are low. In the five previ- 
ously reported cases (1,2,4), three had bilateral effu- 
sion and the other two were on the left side; two cases 
were recurrent. 
The pathogenesis of subpleural inflammation in 
pleuritis with AS remains unknown. Transbronchial 
biopsy specimens of the lung in AS showed intersti- 
tial fibrosis of a variable degree in five cases out of 12 
(41.5%) (8). The fibrosing inflammatory process of 
pleura might have been caused by contiguous exten- 
sion of the vertebral inflammatory fibrosis into the 
pulmonary parenchyma and subpleural space. 
There are no reports of a temporal relationship 
between activity in the spinal column and pleural 
disease, or of the response to the treatment of pleural 
effusion in AS. The effusion was applied for some 
weeks and no treatment was required in three 
patients (l), although systemic administration of 
30 mg day ~ r of prednisolone (2), or indomethacin 
(3), or 200 mg day- ’ of phenylbutazone (4) in 
another three patients did clear the effusions. As our 
case had been treated with various non-steroidal 
anti-inflammatory drugs for years, these drugs were 
not instilled into the pleural effusion. After intra- 
pleural administration of steroid, the effusion built 
up slightly and did not increase over the following 9 
months. Kinnear et al. (2) reported a case with 
bilateral pleural effusion complicating AS, and the 
effusion resolved completely after systemic adminis- 
tration of 30 mg of prednisolone. This case has some 
similarities to our case, but we are not able to explain 
the mechanism of the therapeutic effect of predniso- 
lone. On the other hand, pericarditis is a rare 
association of AS which responds well to steroids (9), 
‘and uveitis associated with AS also responds to local 
steroid therapy. These were the reasons for choosing 
the successful steroid therapy. 
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